EUVIMEDEUVIMED entdecken
Crossref

Drug Repurposing During The COVID-19 Pandemic: Lessons For Expediting Drug Development And Access

Wesley Greenblatt, Charu Gupta, Jennifer Kao

Health Affairs · 2023

DOI: 10.1377/hlthaff.2022.01083 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Health Affairs, 2023. Verfasst von Wesley Greenblatt und 2 weiteren Autor:innen. Beteiligte Einrichtung: Wesley Greenblatt, Harvard University, Boston Children's Hospital, and Massachusetts Institute of Technology, Boston, Massachusetts. Hauptthemen laut MEDLINE: Drug Repositioning, COVID-19. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug RepositioningCOVID-19HumansPandemicsDrug DevelopmentAdministrative Personnel

Autor:innen und Institutionen

  • Wesley Greenblatt, Harvard University, Boston Children's Hospital, and Massachusetts Institute of Technology, Boston, Massachusetts.
  • Charu Gupta, University of California Los Angeles, Los Angeles, California.
  • Jennifer Kao (jennifer.kao@anderson.ucla.edu), University of California Los Angeles.

Zitieren

APA

Greenblatt, W., Gupta, C., & Kao, J. (2023). Drug Repurposing During The COVID-19 Pandemic: Lessons For Expediting Drug Development And Access. Health Affairs. https://doi.org/10.1377/hlthaff.2022.01083

Vancouver

Greenblatt W, Gupta C, Kao J. Drug Repurposing During The COVID-19 Pandemic: Lessons For Expediting Drug Development And Access. Health Affairs. 2023. doi:10.1377/hlthaff.2022.01083

BibTeX
@article{Greenblatt2023,
  author = {Greenblatt, Wesley and Gupta, Charu and Kao, Jennifer},
  title = {Drug Repurposing During The COVID-19 Pandemic: Lessons For Expediting Drug Development And Access},
  journal = {Health Affairs},
  year = {2023},
  doi = {10.1377/hlthaff.2022.01083}
}
Kostenlos starten →